Stock listing
Devonian Health Group, Inc.
Selected listing: GSD · TSXV · CAD · CA
Devonian Health Group, Inc. (TSXV:GSD), Health Technology. Latest release Sep 11, 2026: Devonian Health Group Inc. Anticipates to Commence Trading on the NYSE…
- Ticker
- TSXV:GSD
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TSXV
- Currency
- CAD
About Devonian Health Group, Inc.
The company focuses on developing health-related products and solutions. Its operations are aimed at advancing innovative approaches in the health sector.
Latest news from Devonian Health Group, Inc.
Devonian Health Group Inc. Anticipates to Commence Trading on the NYSE American
September 11, 2026
Devonian Health Group Strengthens Thykamine™ Manufacturing Platform with Validated Chemical-Composition Fingerprinting and Biological Potency Assay
September 1, 2026
Devonian Health Group Anticipates to Commence Trading on the NYSE American
August 18, 2026
Devonian Health Group Announces Proposed Listing on the NYSE American with Concurrent Underwritten Public Offering
July 26, 2026
Devonian Health Group Receives Health Canada Authorization to Initiate Phase II/III Pediatric Clinical Trial of Thykamine™ for Mild-to-Moderate Atopic Dermatitis in Patients Aged 3 Months to 17 Years
July 21, 2026
Research Devonian Health Group, Inc.
Devonian Health Group, Inc. company profile
View the public company page for Devonian Health Group, Inc. on 6ix.
Devonian Health Group, Inc. news
Read company news and market updates connected to Devonian Health Group, Inc..
Devonian Health Group, Inc. investor events
Find investor webinars, events, and replay context for Devonian Health Group, Inc..